Home/Filings/SCHEDULE 13G/0000935836-25-000414
SCHEDULE 13G//SEC Filing

AN2 Therapeutics, Inc. SCHEDULE 13G

Accession 0000935836-25-000414

CIK 0002062655other

Filed

Jun 3, 8:00 PM ET

Accepted

Jun 4, 5:44 PM ET

Size

20.6 KB

Accession

0000935836-25-000414

Issuer

Coastlands Capital Partners LP

CIK 0002062655

Entity typeother
IncorporatedDE

Related Parties

1
  • filerCIK 0002062655

Filing Metadata

Form type
SCHEDULE 13G
Filed
Jun 3, 8:00 PM ET
Accepted
Jun 4, 5:44 PM ET
Size
20.6 KB